Skip to content
akaturk Academic measurement

Academician

MEHMET KARABULUT

PROFESÖR

FENERBAHÇE ÜNİVERSİTESİ SAĞLIK HİZMETLERİ MESLEK YÜKSEKOKULU TIBBİ HİZMETLER VE TEKNİKLER BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Genel Cerrahi

A quick look at recorded outputs — details below.

  • Articles 44
  • Projects 0
  • Books 0
  • Proceedings 69
  • Patents 0
  • Artistic 0
Scopus (SJR) Q1 4 Q2 8 Q3 9 Q4 5
WoS (JCR) Q1 0 Q2 4 Q3 7 Q4 15
TR Index 9 articles

Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.

Top 1% articles 0
Top 10% articles 0
Avg percentile 57.6%
Top 1% share 0.0%
Top 10% share 0.0%

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

Index filters

44 publications total

Article list

  1. 2019 Serum IL-17 levels can be diagnostic for gastric cancer JBUON DOI 2019 24(4): 1601-1609 YÖKSİS SJR Q3 JCR Q4
  2. 2019 Laparoskopik Sleeve Gastrektomi Sonrası Kaçakların Tespitinde Presepsinin Tanısal Değeri: Pilot Çalışma. Medical Journal of Bakirkoy, YÖKSİS TR Index SJR Q4 JCR Q4
  3. 2018 The value of serum survivin level in early diagnosis of cancer Journal of Cancer Research and Therapeutics DOI 10.4103/0973-1482.171369 YÖKSİS SJR Q3 JCR Q4 OpenAlex 76.3%
  4. 2018 Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer Biomolecules Therapeutics DOI 10.3390/biom8040169 YÖKSİS SJR Q1 JCR Q2 OpenAlex 54.7%
  5. 2018 Can 3.0 Tesla diffusion tensor Imaging parameters be prognostic indicators in breast cancer? CLINICAL IMAGING DOI 10.1016/j.clinimag.2018.03.022 YÖKSİS SJR Q3 JCR Q4 OpenAlex 68.7%
  6. 2017 Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma J Infec Chemother YÖKSİS
  7. 2017 Serum interleukin-32 (IL-32) levels may have diagnostic and prognostic roles in patients with pancreatic adenocarcinoma Acta Medica Mediterranea YÖKSİS
  8. 2017 THE EFFECT OF PRETREATMENT NEUTROPHIL/LEUCOCYTE RATIO ON SURVIVAL IN PATIENTS WİTH LOCALLY ADVANCED ESOPHAGEAL CANCER RECEIVING CHEMORADIOTHERAPY ACTA MEDİCA MEDİTERRANEA YÖKSİS
  9. 2017 CIRCULATING MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1/CCL-2) AS A POTENTIALBIOMARKER FOR THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA ACTA MEDİCA MEDİTERRANEA DOI 10.19193/0393-6384_2017_3_075 YÖKSİS
  10. 2017 Evaluation of epidermal growth factor receptor serum levels and their association with clinicopathological characteristics in patients with colorectal cancer Molecular and Clinical Oncology DOI 10.3892/mco.2017.1405 YÖKSİS SJR Q4 JCR Q4 OpenAlex 49.2%
  11. 2016 Is non-operative approach applicable for penetrating injuries of the left thoraco-abdominal region? Turkish Journal of Emergency Medicine DOI 10.1016/j.tjem.2016.02.005 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 84.2%
  12. 2016 Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma BBA Clinical DOI 10.1016/j.bbacli.2016.10.002 YÖKSİS SJR Q2 OpenAlex 86.9%
  13. 2016 Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma Journal of Gastrointestinal Cancer DOI 10.1007/s12029-015-9787-z YÖKSİS SJR Q3 JCR Q4 OpenAlex 64.3%
  14. 2016 Clinical significance of serum interleukin-17 levels in colorectal cancer patients JBUON YÖKSİS SJR Q3 JCR Q4
  15. 2016 CIRCULATING MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA (MIP1- Α) AS A POTENTIALBIOMARKER FOR THE DIAGNOSIS OF PATIENTS WITH PANCREATIC ADENOCARCINOMA Acta Medica Mediterranea DOI 10.19193/0393.6384.2016.4.128 YÖKSİS
  16. 2016 SERUM LEPTİN LEVELS MAY HAVE DİAGNOSTİC AND PREDİCTİVE ROLES İN PATİENTS WİTH PANCREATİC ADENOCARSİNOMA TREATED WİTH GEMCİTABİNE-BASED CHEMOTHERAPY JOURNAL BALKAN UNİON ONCOLOJİC NATİONAL YÖKSİS
  17. 2016 Plasma calprotectin values in acute pancreatitis Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy DOI 10.5350/BTDMJB201612102 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 4.4%
  18. 2015 Serum neural precursor cell expressed developmentally down regulated 9 NEDD9 level may have a prognostic role in patients with gastric cancer Biomedicine & Pharmacotherapy DOI 10.1016/j.biopha.2015.06.010 YÖKSİS SJR Q2 JCR Q3 OpenAlex 68.3%
  19. 2015 CLINICAL SIGNIFICANCE OF SERUM HEPATOCYTE GROWTH FACTOR (HGF) AND ITS RECEPTORCMET LEVELS IN COLORECTAL CANCER PATIENTS Acta Medica Mediterranea DOI 10.19193/0393-6384 YÖKSİS
  20. 2015 Diagnostic importance of S100A9 and S100A12 in breast cancer Biomedicine Pharmacotherapy DOI 10.1016/j.biopha.2015.10.029 YÖKSİS SJR Q2 JCR Q3 OpenAlex 66.7%

Back to academicians